Nzyme Private Equity Fund Closes at €160 Million
– Nzyme, a private equity fund backed by Kibo Ventures, has closed at €160 million.
– Nzyme, a private equity fund backed by Kibo Ventures, has closed at €160 million.
– Hayfin announced strategic partnerships with Mubadala Investment Company and AXA IM Prime (part of AXA IM – BNP Paribas
– Petershill at Goldman Sachs Alternatives announced the sale of its stake in Harvest Partners.
– The Riverside Company closed Riverside Value Fund II (RVF II) at its hard cap
– Blue Owl Capital Inc. has completed the final close of its alternative credit fund,